Priorix: use extended in children

The licence for Priorix (combined measles, mumps and rubella vaccine) has been extended to include use in children aged 9 months or older.

Previously, Priorix was not recommended for use in children under 12 months of age

Further information: GlaxoSmithKline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more